Jump to Navigation

Treatment of ADHD

September, 2006 | Vol: 4 Issue: 9

In this issue

Article

Psychostimulants and ADHD

Recently three new psychostimulant formulations have been approved (Daytrana, the Ritalin patch, and Focalin XR), and one older medication received a new indication (Adderall XR is now indicated for adult ADHD).

Daytrana: A Long and Winding Road to Approval

On April 6, 2006, the FDA announced the approval of Daytrana, a transdermal patch version of Ritalin (methylphenidate). While you wouldn’t know it by the gushy promotional copy on Daytrana’s website (www.daytrana.com), the Ritalin patch just barely squeaked through the FDA approval process.

Sparlon and ADHD: The Power of a 7-Year Old

Rarely has a 7-year old with a rash caused the stock price of a major corporation to gyrate so dramatically.

The Value of an ADHD Diagnosis

A Patient’s Perspective

Expert QA